Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126249051 | 12624905 | 1 | I | 20160705 | 20160728 | 20160805 | 20160805 | PER | US-PFIZER INC-2016367991 | PFIZER | 60.00 | YR | M | Y | 147.00000 | KG | 20160805 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126249051 | 12624905 | 1 | PS | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | 150 MG IN MORNING AND 75MG IN THE EVENING | U | 20699 | 225 | MG | TABLET | |||||||
| 126249051 | 12624905 | 2 | SS | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, DAILY | U | 20699 | 75 | MG | TABLET | ||||||
| 126249051 | 12624905 | 3 | SS | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 175 MG, 1X/DAY | U | 20699 | 175 | MG | TABLET | QD | |||||
| 126249051 | 12624905 | 4 | SS | TRINTELLIX | VORTIOXETINE HYDROBROMIDE | 1 | Oral | 10 MG, 1X/DAY | 140 | MG | Y | 0 | 10 | MG | QD | ||||
| 126249051 | 12624905 | 5 | C | BUSPIRONE | BUSPIRONE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 126249051 | 12624905 | 6 | C | LISINOPRIL HCTZ | HYDROCHLOROTHIAZIDELISINOPRIL | 1 | UNK | 0 | |||||||||||
| 126249051 | 12624905 | 7 | C | INVOKANA | CANAGLIFLOZIN | 1 | UNK | 0 | |||||||||||
| 126249051 | 12624905 | 8 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 126249051 | 12624905 | 9 | C | ASPIRIN. | ASPIRIN | 1 | UNK | 0 | |||||||||||
| 126249051 | 12624905 | 10 | C | GABAPENTIN. | GABAPENTIN | 1 | UNK | 0 | |||||||||||
| 126249051 | 12624905 | 11 | C | HUMLOG | 2 | UNK | 0 | INJECTION | |||||||||||
| 126249051 | 12624905 | 12 | C | KRILL OIL | DIETARY SUPPLEMENT | 1 | UNK | 0 | |||||||||||
| 126249051 | 12624905 | 13 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 126249051 | 12624905 | 14 | C | BYDUREON | EXENATIDE | 1 | UNK | 0 | |||||||||||
| 126249051 | 12624905 | 15 | C | PRAVASTATIN. | PRAVASTATIN | 1 | UNK | 0 | |||||||||||
| 126249051 | 12624905 | 16 | C | TESTOSTERONE. | TESTOSTERONE | 1 | 1 %, UNK | 0 | 1 | PCT | GEL |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126249051 | 12624905 | 1 | Anger |
| 126249051 | 12624905 | 4 | Major depression |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126249051 | 12624905 | Agitation | |
| 126249051 | 12624905 | Dizziness | |
| 126249051 | 12624905 | Drug ineffective for unapproved indication | |
| 126249051 | 12624905 | Gastric disorder | |
| 126249051 | 12624905 | Irritability | |
| 126249051 | 12624905 | Nausea | |
| 126249051 | 12624905 | Nightmare | |
| 126249051 | 12624905 | Sedation | |
| 126249051 | 12624905 | Sleep disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126249051 | 12624905 | 4 | 20160622 | 20160706 | 0 |